{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T19:31:12Z","timestamp":1705433472072},"reference-count":29,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2008,2,20]],"date-time":"2008-02-20T00:00:00Z","timestamp":1203465600000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cathet Cardio Intervent"],"published-print":{"date-parts":[[2008,2,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:styled-content>Background<\/jats:styled-content>: In selected patient cohorts the polymer\u2010free rapamycin\u2010eluting YUKON stent (A) has demonstrated noninferiority compared with the polymer\u2010based paclitaxel\u2010eluting TAXUS stent (B). To test for equivalency in unselected real\u2010world patients with coronary lesions of various complexities, we retrospectively compared both stent designs. <jats:styled-content>Methods<\/jats:styled-content>: A total of 410 patients with symptomatic CAD were successfully treated with A (<jats:italic>n<\/jats:italic> = 205) or with B (<jats:italic>n<\/jats:italic> = 205). Baseline clinical characteristics, coronary lesion location, lesion length, and the number of stents implanted per lesion were equally distributed between the treatment groups. All patients underwent QCA\u2010analysis at baseline. Clinical follow\u2010up with assessment of MACE and noncardiac deaths was obtained at 30 days and 6 months. <jats:styled-content>Results<\/jats:styled-content>: Nominal stent diameter was 2.96 \u00b1 0.38 mm in Group A vs. 3.05 \u00b1 0.42 mm in Group B (<jats:italic>P<\/jats:italic> = 0.2); nominal length of stented segmentwas 22.97 \u00b113.0 mm vs. 23.63 \u00b1 10.0 (<jats:italic>P<\/jats:italic> = 0.56). Analysis of MACE after 6 months resulted in one angiographically documented stent thrombosis causing MI in B (0.2%) vs. none in A. No other MI or cardiac deaths occurred in either group, while two noncardiac deaths in A (1.0%) were reported. Fifteen target lesion revascularizations (7.3%) were performed in A vs. 7 (3.4%) in B. Differences in study endpoints at 6 months did not reach statistical significance (<jats:italic>P<\/jats:italic> &gt; 0.05). <jats:styled-content>Conclusions<\/jats:styled-content>: Up to 6 months after PCI of real\u2010world coronary lesions, there were no statistically significant differences in MACE between patients treated with the polymer\u2010free rapamycin\u2010eluting YUKON stent and the polymer\u2010based paclitaxel\u2010eluting TAXUS stent. \u00a9 2008 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/ccd.21326","type":"journal-article","created":{"date-parts":[[2008,2,21]],"date-time":"2008-02-21T07:18:19Z","timestamp":1203578299000},"page":"333-339","source":"Crossref","is-referenced-by-count":21,"title":["Comparison of a polymer\u2010free rapamycin\u2010eluting stent (YUKON) with a polymer\u2010based paclitaxel\u2010eluting stent (TAXUS) in real\u2010world coronary artery lesions"],"prefix":"10.1002","volume":"71","author":[{"given":"Johannes","family":"Ruef","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"St\u00f6rger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Haase,","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,2,20]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(03)00153-4"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067193"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000069330.41022.90"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067484"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp068305"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa066633"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067722"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.575977"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000157579.52566.ee"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.1810300205"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.1.91"},{"key":"e_1_2_5_13_2","first-page":"562","article-title":"Comparison of stainless steel stents coated with turbostratic carbon and uncoated stents for percutaneous coronary interventions","volume":"15","author":"Haase J","year":"2003","journal-title":"J Invasive Cardiol"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.666826"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-143-5-200509060-00119"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.03.042"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.94.7.1690"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.11.081"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000116202.41966.D4"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000041632.02514.14"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.04.040"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00019501-200409000-00003"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.675934"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.09.047"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.20895"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.20926"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.20400"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi405"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032441"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp068304"}],"container-title":["Catheterization and Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fccd.21326","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ccd.21326","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T07:38:02Z","timestamp":1697614682000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ccd.21326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,15]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,2,15]]}},"alternative-id":["10.1002\/ccd.21326"],"URL":"https:\/\/doi.org\/10.1002\/ccd.21326","archive":["Portico"],"relation":{},"ISSN":["1522-1946","1522-726X"],"issn-type":[{"value":"1522-1946","type":"print"},{"value":"1522-726X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,15]]}}}